Clinical Trial

Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)

Name: Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) — clinical trial record (NCT06454110)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase II, open-label study designed to To evaluate the safety and efficacy of NM8074 in reducing proteinuria relative to baseline in IgAN patients after 99 days of treatment.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-06-06; most recent amendment 2026-04-07.

Trial Details

NCT Number	NCT06454110
Lead Sponsor	NovelMed Therapeutics
Conditions	IgA Nephropathy
Enrollment	10 participants
Start Date	2028-02
Primary Completion	2030-12 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-13